Dr. Lu Chen 陈鲁
Chief Physician
Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and medical management of gynecologic malignancies (cervical, ovarian, endometrial, vulvar cancers) and benign conditions. Expertise includes open, laparoscopic, and robotic surgery, fertility-sparing procedures, chemotherapy, immunotherapy, targeted therapy, and complication management.
Dr. Lu Chen is a Chief Physician and master’s supervisor with a master’s degree. A visiting scholar at Aschaffenburg Medical Center in Germany, Dr. Chen has led six provincial/ministerial projects and participated in over ten national or provincial projects. Publications include nine SCI-indexed papers and more than 30 other articles. Dr. Chen holds one utility model patent.
Professional roles
- Member, Gynecologic Oncology Integrated Rehabilitation Committee, China Anti-Cancer Association
- Standing Committee Member, Gynecologic Oncology Professional Committee, Zhejiang Anti-Cancer Association
- Member, Gynecologic Oncology Branch, Zhejiang Medical Association
Name order: in Chinese the family name comes first (Chen Lu). Papers usually list the name as Lu Chen or Chen L.
Selected publications
20 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Animal Model Exp Med, 2026 (first author): Zebrafish xenograft models as a fast platform for metastasis diagnosis and cisplatin response of head and neck squamous cell carcinoma. PubMed 42625288
- Medicine (Baltimore), 2022 (senior author): Leiomyomatosis peritonealis disseminata with low-grade malignant change: A case report. PubMed 36086674
- Asia Pac J Clin Oncol, 2022 (senior author): miR-425 regulates ovarian cancer proliferation, metastasis, and apoptosis by repressing PAK4 expression. PubMed 33765367
- Bioengineered, 2021 (senior author): LETM1 (leucine zipper-EF-hand-containing transmembrane protein 1) silence reduces the proliferation, invasion, migration and angiogenesis in esophageal squamous cell carcinoma via KIF14 (kinesin family member 14). PubMed 34605738
- Onco Targets Ther, 2018 (senior author): ALDH1A2 suppresses epithelial ovarian cancer cell proliferation and migration by downregulating STAT3. PubMed 29430185
- Oncol Lett, 2015 (senior author): Squamous cell carcinoma of unknown primary site presenting with an abdominal wall lesion as the primary symptom: A case report and review of the literature. PubMed 26622812
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion